Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants
- PMID: 2522492
- DOI: 10.1002/jlb.45.3.262
Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants
Abstract
Mice bearing large (greater than or equal to 3 g) metastatic and nonmetastatic Lewis lung carcinoma (LLC) tumors were studied to determine if the tumor variants differentially induced bone marrow versus splenic hematopoiesis and the appearance of hematopoiesis-associated immune suppressor cells. The metastatic LLC-C3 and nonmetastatic LLC-C8 tumors were equal in their stimulatory effects in vivo on both the number of bone marrow myeloid progenitor cells (CFU) and the appearance of bone marrow immune suppressor cells. In contrast, the tumor variants differed in their effects on the spleen, with the metastatic tumors causing a more pronounced increase in the number of nucleated cells and CFU, a reduced blastogenic responsiveness to concanavalin (Con-A), and an increased suppressor cell activity than nonmetastatic LLC-C8 tumors. The splenic suppressor cells of mice bearing large LLC-C3 tumors resembled the bone marrow suppressor cells which we previously described (Young et al.: Cancer Res. 47, 100, 1987) in that they were nonadherent to nylon wool, sensitive to treatment with L-leucine methyl ester, insensitive to treatment with complement and Thy-1.2, MG-1.2, asialo-GM1, or anti-IgM antibodies, and mediated their suppression through a mechanism which was only partially indomethacin sensitive. The stimulatory effects on hematopoiesis and suppressor cells by the LLC variant tumors may have been mediated by the tumor-derived colony stimulating factor (CSF) activities. Bone marrow cell proliferation and colony formation were stimulated in vitro by culture supernatants of metastatic LLC-C3 cells and, to a lesser degree, of nonmetastatic LLC-C8 cells. These colony-stimulating factor (CSF)-containing supernatants also induced normal bone marrow cells to become immune suppressive. In contrast, supernatants of only LLC-C3 cells, and not of LLC-C8 cells, stimulated in vitro growth of splenic CFU from LLC-C3-bearing mice; spleen cells from normal mice and from LLC-C8 bearers were unresponsive to supernatants of the LLC variants. These results suggest that CSF produced by either the metastatic LLC-C3 or the nonmetastatic LLC-C8 tumors could concurrently stimulate bone marrow hematopoiesis and the appearance of bone marrow suppressor cells. However, the metastatic LLC-C3 tumor cells, and not the nonmetastatic LLC-C8 cells, could also cause expansion of progenitor cells and hematopoiesis to the spleen and, consequently, induce the appearance in the spleen of hematopoiesis-associated immune suppressor cells.
Similar articles
-
Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.Cancer Res. 1987 Jan 1;47(1):100-5. Cancer Res. 1987. PMID: 2947676
-
The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.Exp Hematol. 1988 May;16(4):295-301. Exp Hematol. 1988. PMID: 2966070
-
Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.Cancer Res. 1988 Dec 1;48(23):6826-31. Cancer Res. 1988. PMID: 2972359
-
Effects of Bestatin on hematopoiesis in long-term human bone marrow cultures.Biomed Pharmacother. 1995;49(2):69-74. doi: 10.1016/0753-3322(96)82589-3. Biomed Pharmacother. 1995. PMID: 7605904 Review.
-
Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells.Cancer Metastasis Rev. 1984;3(1):5-24. doi: 10.1007/BF00047690. Cancer Metastasis Rev. 1984. PMID: 6370419 Review.
Cited by
-
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.J Immunol. 2018 Jan 15;200(2):422-431. doi: 10.4049/jimmunol.1701019. J Immunol. 2018. PMID: 29311384 Free PMC article. Review.
-
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes.Proc Natl Acad Sci U S A. 2014 May 27;111(21):7771-6. doi: 10.1073/pnas.1402914111. Epub 2014 May 13. Proc Natl Acad Sci U S A. 2014. PMID: 24825888 Free PMC article.
-
Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.Cancer Immunol Immunother. 1994 Jan;38(1):9-15. doi: 10.1007/BF01517164. Cancer Immunol Immunother. 1994. PMID: 8299123 Free PMC article.
-
Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells.Neoplasia. 2008 Jun;10(6):549-62. doi: 10.1593/neo.08286. Neoplasia. 2008. PMID: 18516292 Free PMC article.
-
The role of myeloid derived suppressor cells in musculoskeletal disorders.Front Immunol. 2023 Mar 3;14:1139683. doi: 10.3389/fimmu.2023.1139683. eCollection 2023. Front Immunol. 2023. PMID: 36936946 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous